https://www.taxtmi.com/caselaws?id=213693 ITAT held in favor of the assessee on multiple counts: weighted deduction under s.35(2AB) allowed for clinical trials/bio-equivalence studies conducted using organizational staff/resources in an approved in-house facility; s.80IC deduction not to be denied by treating Baddi unit sales as deemed inter-unit transfers or by segregating profits; legal/professional expenses for business expansion treated as revenue, not pre-operative capital; product/trademark/patent registration and related support reimbursements held revenue in nature, not depreciable intangible assets. Disallowance under s.14A was remanded to AO. Transfer pricing adjustments were sent back for reconsideration (DRP's 2% markup left intact). For MAT, provision for doubtful debts added to book profits (against assessee); MAT credit carry-forward remitted to AO for determination. en-us Fri, 25 May 2012 00:00:00 +0530 Fri, 05 Sep 2025 12:46:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=213693 ITAT held in favor of the assessee on multiple counts: weighted deduction under s.35(2AB) allowed for clinical trials/bio-equivalence studies conducted using organizational staff/resources in an approved in-house facility; s.80IC deduction not to be denied by treating Baddi unit sales as deemed inter-unit transfers or by segregating profits; legal/professional expenses for business expansion treated as revenue, not pre-operative capital; product/trademark/patent registration and related support reimbursements held revenue in nature, not depreciable intangible assets. Disallowance under s.14A was remanded to AO. Transfer pricing adjustments were sent back for reconsideration (DRP's 2% markup left intact). For MAT, provision for doubtful debts added to book profits (against assessee); MAT credit carry-forward remitted to AO for determination. Case-Laws Income Tax Fri, 25 May 2012 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=213693